Absence of socioeconomic variation in survival from colorectal cancer in patients receiving surgical treatment in one health district: cohort study
Article first published online: 1 NOV 2004
Volume 6, Issue 6, pages 512–517, November 2004
How to Cite
Lyratzopoulos, G., Sheridan, G. F., Michie, H. R., McElduff, P. and Hobbiss, J. H. (2004), Absence of socioeconomic variation in survival from colorectal cancer in patients receiving surgical treatment in one health district: cohort study. Colorectal Disease, 6: 512–517. doi: 10.1111/j.1463-1318.2004.00717.x
- Issue published online: 1 NOV 2004
- Article first published online: 1 NOV 2004
- Received 22 October 2003; accepted 15 June 2004
- Colorectal cancer;
- socioeconomic variation;
- health district;
- cohort study
Objective To examine whether there is an association between patient deprivation status and survival from colorectal cancer among patients receiving treatment of the same type and quality.
Patients and methods A survival study was conducted of all colorectal cancer patients diagnosed between 1991 and 1997 who received surgery either in the NHS district general hospital or the private hospital of one UK health district. The five-year survival rates, both all cause and colorectal cancer specific, were calculated for subgroups defined by patient age, gender, stage and deprivation status using Kaplan-Meier curves. Cox proportional hazards models were used to examine the influence of deprivation on five-year survival after adjusting for age, gender and stage.
Results There were 603 consecutive colorectal patients during the study period. Five-year all-cause and colorectal cancer-specific survival rates were 41% and 53%, respectively. There was no association between deprivation status and stage at diagnosis (P = 0.308). Multivariable proportional hazards modelling (adjusting for gender, age and tumour stage) demonstrated no association between deprivation status and survival.
Conclusion In this single district study, no relationship between patient socioeconomic status and survival from colorectal cancer could be demonstrated. Consistency in the type and quality of treatment offered to patients by the same clinical teams may have been responsible for the equitable survival outcomes.